FLAGSTAFF, Ariz.— W. L. Gore & Associates, Inc. (Gore) today announced at the American Society for Metabolic and Bariatric Surgery Meeting that it has received approval from Health Canada for GORE® SEAMGUARD® Bioabsorbable Staple Line Reinforcement. The device is specifically engineered to reduce the incidence of perioperative leaks and bleeding in a variety of open and minimally invasive surgeries. With more than 15 years of bioabsorbable material technology research and clinical use supporting it, GORE SEAMGUARD Bioabsorbable Staple Line Reinforcement has a proven record of safety. Worldwide, more than 500,000 successful implants have been completed and more than 40 clinical papers have documented its successful use in bariatric, colorectal and thoracic procedures.
GORE SEAMGUARD Bioabsorbable Staple Line Reinforcement is 100 percent bioabsorbable with a synthetic tissue scaffold. It is engineered for consistent thinness to allow proper staple formation. While providing added strength to the staple line during the critical healing process, this reinforcement is gradually and predictably absorbed, usually within six months. The risk of a prolonged inflammatory response is eliminated.